NCT02820350View on ClinicalTrials.gov

Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI).

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 4, 2016

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Acute Kidney Injury
Interventions
DEVICE

SCD-F40

CRRT with SCD

Trial Locations (4)

30322

Children's Healthcare of Atlanta at Egleston, Atlanta

35233

Children's Hospital of Alabama, Birmingham

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

48109

CS Mott Children's Hospital, Ann Arbor

Sponsors

Lead Sponsor

CytoPherx, Inc
All Listed Sponsors
collaborator

Innovative BioTherapies (IBT)

INDUSTRY

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

lead

CytoPherx, Inc

INDUSTRY

NCT02820350 - Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI). | Biotech Hunter | Biotech Hunter